Consistently Replicating Locus Linked to Migraine on 10q22-q23

American Journal of Human Genetics

Volumn 82, Issue 5, 2008, Pages 1051-1063

  Anttila, Verneri ^a,b,i   Nyholt, Dale R ^c   Kallela, Mikko ^b   Artto, Ville ^b   Vepsäläinen, Salli ^b   Jakkula, Eveliina ^a,g,h   Wennerström, Annika ^a   Tikka Kleemola, Päivi ^a   Kaunisto, Mari A ^a,d   Hämäläinen, Eija ^a   Widén, Elisabeth ^a   Terwilliger, Joseph ^a,e   Merikangas, Kathleen ^f   Montgomery, Grant W ^c   Martin, Nicholas G ^c   Daly, Mark ^h   Kaprio, Jaakko ^a,g   Peltonen, Leena ^a,g,h,i   Färkkilä, Markus ^b   Wessman, Maija ^a,b,d   Palotie, Aarno ^a,b,h,i   more..

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^d FOLKHÄLSAN RESEARCH CENTER   (Finland)

^e Columbia University ^*  (United States)

^f NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^g NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^h MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

ⁱ WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUSTRALIA; CHROMOSOME 10Q; CHROMOSOME NOR; CONTROLLED STUDY; FEMALE; FINLAND; FOLLOW UP; GENE LOCUS; GENE REPLICATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC VARIABILITY; GENOME; HUMAN; LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIGRAINE; PHENOTYPE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SYMPTOMATOLOGY;

AUSTRALIA; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 10; FEMALE; FINLAND; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LOD SCORE; MALE; MIGRAINE DISORDERS;

EID: 42749088307     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajhg.2008.03.003     Document Type: Article

References (59)

1. Stovner L.J., Zwart J.A., Hagen K., Terwindt G.M., and Pascual J. Epidemiology of headache in Europe. Eur. J. Neurol. 13 (2006) 333-345
2. Launer L.J., Terwindt G.M., and Ferrari M.D. The prevalence and characteristics of migraine in a population-based cohort: The GEM study. Neurology 53 (1999) 537-542
3. Mulder E.J., Van Baal C., Gaist D., Kallela M., Kaprio J., Svensson D.A., Nyholt D.R., Martin N.G., MacGregor A.J., Cherkas L.F., et al. Genetic and environmental influences on migraine: a twin study across six countries. Twin Res. 6 (2003) 422-431
4. Russell M.B., and Olesen J. Increased familial risk and evidence of genetic factor in migraine. BMJ 311 (1995) 541-544
5. Andlin-Sobocki P., Jonsson B., Wittchen H.U., and Olesen J. Cost of disorders of the brain in Europe. Eur. J. Neurol. 12 Suppl 1 (2005) 1-27
6. Honkasalo M.L., Kaprio J., Winter T., Heikkila K., Sillanpaa M., and Koskenvuo M. Migraine and concomitant symptoms among 8167 adult twin pairs. Headache 35 (1995) 70-78
7. Larsson B., Bille B., and Pederson N.L. Genetic influence in headaches: A Swedish twin study. Headache 35 (1995) 513-519
8. Nyholt D.R., Morley K.I., Ferreira M.A., Medland S.E., Boomsma D.I., Heath A.C., Merikangas K.R., Montgomery G.W., and Martin N.G. Genomewide significant linkage to migrainous headache on chromosome 5q21. Am. J. Hum. Genet. 77 (2005) 500-512
9. Wessman M., Kallela M., Kaunisto M.A., Marttila P., Sobel E., Hartiala J., Oswell G., Leal S.M., Papp J.C., Hamalainen E., et al. A susceptibility locus for migraine with aura, on chromosome 4q24. Am. J. Hum. Genet. 70 (2002) 652-662
10. Lea R.A., Nyholt D.R., Curtain R.P., Ovcaric M., Sciascia R., Bellis C., Macmillan J., Quinlan S., Gibson R.A., McCarthy L.C., et al. A genome-wide scan provides evidence for loci influencing a severe heritable form of common migraine. Neurogenetics 6 (2005) 67-72
11. Anttila V., Kallela M., Oswell G., Kaunisto M.A., Nyholt D.R., Hamalainen E., Havanka H., Ilmavirta M., Terwilliger J., Sobel E., et al. Trait components provide tools to dissect the genetic susceptibility of migraine. Am. J. Hum. Genet. 79 (2006) 85-99
12. Björnsson A., Gudmundsson G., Gudfinnsson E., Hrafnsdottir M., Benedikz J., Skuladottir S., Kristjansson K., Frigge M.L., Kong A., Stefansson K., and Gulcher J.R. Localization of a gene for migraine without aura to chromosome 4q21. Am. J. Hum. Genet. 73 (2003) 986-993
13. Cader Z.M., Noble-Topham S., Dyment D.A., Cherny S.S., Brown J.D., Rice G.P., and Ebers G.C. Significant linkage to migraine with aura on chromosome 11q24. Hum. Mol. Genet. 12 (2003) 2511-2517
14. Soragna D., Vettori A., Carraro G., Marchioni E., Vazza G., Bellini S., Tupler R., Savoldi F., and Mostacciuolo M.L. A locus for migraine without aura maps on chromosome 14q21.2-q22.3. Am. J. Hum. Genet. 72 (2003) 161-167
15. Carlsson A., Forsgren L., Nylander P.O., Hellman U., Forsman-Semb K., Holmgren G., Holmberg D., and Holmberg M. Identification of a susceptibility locus for migraine with and without aura on 6p12.2-p21.1. Neurology 59 (2002) 1804-1807
16. International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society. Cephalalgia 8 (1988) 1-96
17. International Headache Society. The International classification of headache disorders: 2nd edition. Cephalalgia 24 Suppl 1 (2004) 9-160
18. Nyholt D.R., Gillespie N.G., Heath A.C., Merikangas K.R., Duffy D.L., and Martin N.G. Latent class and genetic analysis does not support migraine with aura and migraine without aura as separate entities. Genet. Epidemiol. 26 (2004) 231-244
19. Blau J.N. Migraine with aura and migraine without aura are not different entities. Cephalalgia 15 (1995) 186-190
20. Ligthart L., Boomsma D.I., Martin N.G., Stubbe J.H., and Nyholt D.R. Migraine with aura and migraine without aura are not distinct entities: Further evidence from a large Dutch population study. Twin Res. Hum. Genet. 9 (2006) 54-63
21. Kallela M., Wessman M., and Färkkilä M. Validation of a migraine specific questionnaire for use in family studies. Eur. J. Neurol. 8 (2001) 61-66
22. Heath A.C., Bucholz K.K., Madden P.A., Dinwiddie S.H., Slutske W.S., Bierut L.J., Statham D.J., Dunne M.P., Whitfield J.B., and Martin N.G. Genetic and environmental contributions to alcohol dependence risk in a national twin sample: Consistency of findings in women and men. Psychol. Med. 27 (1997) 1381-1396
23. Heath A.C., Howells W., Kirk K.M., Madden P.A., Bucholz K.K., Nelson E.C., Slutske W.S., Statham D.J., and Martin N.G. Predictors of non-response to a questionnaire survey of a volunteer twin panel: Findings from the Australian 1989 twin cohort. Twin Res. 4 (2001) 73-80
24. Merikangas K.R., Dartigues J.F., Whitaker A., and Angst J. Diagnostic criteria for migraine. A validity study. Neurology 44 (1994) S11-S16
25. Stewart W.F., Staffa J., Lipton R.B., and Ottman R. Familial risk of migraine: A population-based study. Ann. Neurol. 41 (1997) 166-172
26. O'Connell J.R., and Weeks D.E. PedCheck: A program for identification of genotype incompatibilities in linkage analysis. Am. J. Hum. Genet. 63 (1998) 259-266
27. Abecasis G.R., Cherny S.S., Cookson W.O., and Cardon L.R. Merlin-rapid analysis of dense genetic maps using sparse gene flow trees. Nat. Genet. 30 (2002) 97-101
28. Whittemore A.S., and Halpern J. A class of tests for linkage using affected pedigree members. Biometrics 50 (1994) 118-127
29. Kong A., and Cox N.J. Allele-sharing models: LOD scores and accurate linkage tests. Am. J. Hum. Genet. 61 (1997) 1179-1188
30. Weeks D.E., and Lange K. The affected-pedigree-member method of linkage analysis. Am. J. Hum. Genet. 42 (1988) 315-326
31. Haseman J.K., and Elston R.C. The investigation of linkage between a quantitative trait and a marker locus. Behav. Genet. 2 (1972) 3-19
32. Elston R.C., Song D., and Iyengar S.K. Mathematical assumptions versus biological reality: Myths in affected sib pair linkage analysis. Am. J. Hum. Genet. 76 (2005) 152-156
33. Kruglyak L., Daly M.J., Reeve-Daly M.P., and Lander E.S. Parametric and nonparametric linkage analysis: A unified multipoint approach. Am. J. Hum. Genet. 58 (1996) 1347-1363
34. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A., Bender D., Maller J., Sklar P., de Bakker P.I., Daly M.J., and Sham P.C. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81 (2007) 559-575
35. Lander E., and Kruglyak L. Genetic dissection of complex traits: Guidelines for interpreting and reporting linkage results. Nat. Genet. 11 (1995) 241-247
36. Feingold E., Brown P.O., and Siegmund D. Gaussian models for genetic linkage analysis using complete high-resolution maps of identity by descent. Am. J. Hum. Genet. 53 (1993) 234-251
37. Rao D.C., and Province M.A. The future of path analysis, segregation analysis, and combined models for genetic dissection of complex traits. Hum. Hered. 50 (2000) 34-42
38. Abecasis G.R., Yashar B.M., Zhao Y., Ghiasvand N.M., Zareparsi S., Branham K.E., Reddick A.C., Trager E.H., Yoshida S., Bahling J., et al. Age-related macular degeneration: A high-resolution genome scan for susceptibility loci in a population enriched for late-stage disease. Am. J. Hum. Genet. 74 (2004) 482-494
39. Abecasis G.R., Burt R.A., Hall D., Bochum S., Doheny K.F., Lundy S.L., Torrington M., Roos J.L., Gogos J.A., and Karayiorgou M. Genomewide scan in families with schizophrenia from the founder population of Afrikaners reveals evidence for linkage and uniparental disomy on chromosome 1. Am. J. Hum. Genet. 74 (2004) 403-417
40. Suarez B.K., Duan J., Sanders A.R., Hinrichs A.L., Jin C.H., Hou C., Buccola N.G., Hale N., Weilbaecher A.N., Nertney D.A., et al. Genomewide linkage scan of 409 European-ancestry and African American families with schizophrenia: Suggestive evidence of linkage at 8p23.3-p21.2 and 11p13.1-q14.1 in the combined sample. Am. J. Hum. Genet. 78 (2006) 315-333
41. Wiltshire S., Cardon L.R., and McCarthy M.I. Evaluating the results of genomewide linkage scans of complex traits by locus counting. Am. J. Hum. Genet. 71 (2002) 1175-1182
42. Ophoff R.A., Terwindt G.M., Vergouwe M.N., van Eijk R., Oefner P.J., Hoffman S.M., Lamerdin J.E., Mohrenweiser H.W., Bulman D.E., Ferrari M., et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 87 (1996) 543-552
43. De Fusco M., Marconi R., Silvestri L., Atorino L., Rampoldi L., Morgante L., Ballabio A., Aridon P., and Casari G. Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nat. Genet. 33 (2003) 192-196
44. Dichgans M., Freilinger T., Eckstein G., Babini E., Lorenz-Depiereux B., Biskup S., Ferrari M.D., Herzog J., van den Maagdenberg A.M., Pusch M., and Strom T.M. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet 366 (2005) 371-377
45. Scott L.J., Mohlke K.L., Bonnycastle L.L., Willer C.J., Li Y., Duren W.L., Erdos M.R., Stringham H.M., Chines P.S., Jackson A.U., et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316 (2007) 1341-1345
46. Maller J., George S., Purcell S., Fagerness J., Altshuler D., Daly M.J., and Seddon J.M. Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration. Nat. Genet. 38 (2006) 1055-1059
47. Gudmundsson J., Sulem P., Steinthorsdottir V., Bergthorsson J.T., Thorleifsson G., Manolescu A., Rafnar T., Gudbjartsson D., Agnarsson B.A., Baker A., et al. Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat. Genet. 39 (2007) 977-983
48. Todd J.A., Walker N.M., Cooper J.D., Smyth D.J., Downes K., Plagnol V., Bailey R., Nejentsev S., Field S.F., Payne F., et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat. Genet. 39 (2007) 857-864
49. Saxena R., Voight B.F., Lyssenko V., Burtt N.P., de Bakker P.I., Chen H., Roix J.J., Kathiresan S., Hirschhorn J.N., et al. Diabetes Genetics Initiative of Broad Institute of Harvard and MIT, Lund University, and Novartis Institutes of BioMedical Research. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316 (2007) 1331-1336
50. Amundadottir L.T., Sulem P., Gudmundsson J., Helgason A., Baker A., Agnarsson B.A., Sigurdsson A., Benediktsdottir K.R., Cazier J.B., Sainz J., et al. A common variant associated with prostate cancer in European and African populations. Nat. Genet. 38 (2006) 652-658
51. Haiman C.A., Patterson N., Freedman M.L., Myers S.R., Pike M.C., Waliszewska A., Neubauer J., Tandon A., Schirmer C., McDonald G.J., et al. Multiple regions within 8q24 independently affect risk for prostate cancer. Nat. Genet. 39 (2007) 638-644
52. Gudmundsson J., Sulem P., Manolescu A., Amundadottir L.T., Gudbjartsson D., Helgason A., Rafnar T., Bergthorsson J.T., Agnarsson B.A., Baker A., et al. Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat. Genet. 39 (2007) 631-637
53. Hugot J.P., Laurent-Puig P., Gower-Rousseau C., Olson J.M., Lee J.C., Beaugerie L., Naom I., Dupas J.L., Van Gossum A., Orholm M., et al. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 379 (1996) 821-823
54. Rioux J.D., Xavier R.J., Taylor K.D., Silverberg M.S., Goyette P., Huett A., Green T., Kuballa P., Barmada M.M., Datta L.W., et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat. Genet. 39 (2007) 596-604
55. Wiltshire S., Hattersley A.T., Hitman G.A., Walker M., Levy J.C., Sampson M., O'Rahilly S., Frayling T.M., Bell J.I., Lathrop G.M., et al. A genomewide scan for loci predisposing to type 2 diabetes in a U.K. population (the Diabetes UK Warren 2 Repository): Analysis of 573 pedigrees provides independent replication of a susceptibility locus on chromosome 1q. Am. J. Hum. Genet. 69 (2001) 553-569
56. Grant S.F., Thorleifsson G., Reynisdottir I., Benediktsson R., Manolescu A., Sainz J., Helgason A., Stefansson H., Emilsson V., Helgadottir A., et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat. Genet. 38 (2006) 320-323
57. Helgason A., Pálsson S., Thorleifsson G., Grant S.F., Emilsson V., Gunnarsdottir S., Adeyemo A., Chen Y., Chen G., Reynisdottir I., et al. Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution. Nat. Genet. 39 (2007) 218-225
58. Lundmark F., Duvefelt K., Iacobaeus E., Kockum I., Wallström E., Khademi M., Oturai A., Ryder L.P., Saarela J., Harbo H.F., et al. Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis. Nat. Genet. 39 (2007) 1108-1113
59. Hafler D.A., Compston A., Sawcer S., Lander E.S., Daly M.J., De Jager P.L., de Bakker P.I., Gabriel S.B., Mirel D.B., Ivinson A.J., et al. Risk alleles for multiple sclerosis identified by a genomewide study. N. Engl. J. Med. 357 (2007) 851-862